Small Cap Biotechs

For Biotech and Pharmaceutical Companies

Looking for Financing, PR or Investor Relations Services?

We facilitate introductions to leading hedge funds who share your company's best interests and may be interested in investing in you. We also bump shoulders with some of the premier Investor Relations & PR firms in the United States. We've a track record of success which supports these relationships, and a network that feeds our success. If you have a company in need of greater visibility or capital investment, we'd like to hear from you.

Biotech News and Updates

ADMA Biologics, Inc. (ADMA): Offering is Imminent

April 11, 2019

Comments Off

ADMA Biologics, Inc. (ADMA) shares price almost doubled since company announced that the FDA approved its Asceniv, intravenous immunoglobulin product for the treatment of primary humoral immunodeficiency disease (PIDD), in adults and adolescents

Proteostasis Therapeutics (PTI): Market Overreaction

March 26, 2019

Comments Off

Shares of Proteostasis Therapeutics Inc. (PTI) slightly recovered during today’s trading after huge drop on Monday’s session when company announced results from a phase 1 study of its cystic fibrosis (CF) treatment.

BOSTON,

Sientra (NASDAQ: SIEN) : DD and More

December 13, 2015

Comments Off

A few excerpts:

PennyStockHaven:

From Sientra’s (SIEN) 8-K filing from October 30th, 2015:
We continue to be well funded with a cash and cash equivalents balance of $148.9 million as of September 30, 2015. Earlier

SANUWAVE (SNWV): U.S. Patent to Sterilize Blood Using SNWV’s Shock Wave Technology

April 11, 2013

Comments Off

SANUWAVE Health, Inc. (OTCBB:SNWV) has received a patent issued by the U.S. Patent and Trademark Office entitled “Method and Devices for Cleaning and Sterilization with Shock Waves.” The claims of the patent (patent number 8,343,420) relate to a new method that sterilizes

BioCryst Pharmaceuticals (BCRX): Update Regarding Peramivir

April 1, 2013

Comments Off

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) designs, optimizes and develops novel small-molecule drugs that block key enzymes involved in infectious and inflammatory diseases.

BioCryst announced that it received a preliminary comment letter from the FDA that

Cell Therapeutics, Inc.(CTIC): $15MM Loan Financing Agreement

March 28, 2013

Comments Off

Cell Therapeutics, Inc. (CTIC) announced that it has entered into a Loan and Security Agreement with Hercules Technology Growth Capital, Inc. for a senior secured term loan of up to $15 million. The first

With Completion of Spring Bank’s (SBPH) ACHIEVE, All Eyes on Gilead’s Combination Data
Fri, Apr 12
Spring Bank (SBPH) presented data for their Phase 2 ACHIEVE trial at EASL conference today, including · more »
Aldeyra’s Allergic Conjunctivitis Data Positions Candidate Well in Dry Eye Disease
Tue, Mar 26
This morning Aldeyra released topline data for their Phase 3 candidate reproxalap in allergic · more »
Market Overlooking Eventful Upcoming 12 Months for Spring Bank (SBPH)
Fri, Mar 15
Spring Bank provided a business update earlier this week to discuss 2019 development plant for their · more »
Fennec Delays NDA Due to Manufacturing Facility Change
Wed, Mar 13
Fennec announced some bad news this morning. Their NDA submission for Pedmark has been pushed back by · more »
Aldeyra Shares Details On Phase 3 Pipeline Candidates
Thu, Feb 28
This morning, Aldeyra hosted their RD day, where they discussed their pipeline and upcoming plans. · more »
The Street is Finally Starting to Pick Up on Bellus’ Story
Tue, Feb 19
It seems the market is starting to realize Bellus’ potential as the company touched a 52 week high · more »
Fennec’s $12.5M Loan Gives Company Viable Alternative To Commercialize Alone
Mon, Feb 4
Today Fennec (FENC) announced a $12.5 million senior loan with the Life Sciences Group at Bridge Bank. · more »
Aldeyra’s All Stock Deal Could Be Sign Of Validation
Tue, Jan 29
Today, Aldeyra (ALDX) acquired privately company Helio Vision for an all stock deal worth $12.5M, with · more »
Overlooked Name Could Be A Pillar To Cure of Multi-Billion Dollar Disease
Sat, Jan 26
SBPH is developing inarigivir, an immune activator that boosts the efficacy of the immune system · more »

Recent Updates

For Biotech and Pharmaceutical Companies

Looking for Financing, PR or Investor Relations Services?

Biotech News and Updates

ADMA Biologics, Inc. (ADMA): Offering is Imminent

Proteostasis Therapeutics (PTI): Market Overreaction

Sientra (NASDAQ: SIEN) : DD and More

SANUWAVE (SNWV): U.S. Patent to Sterilize Blood Using SNWV’s Shock Wave Technology

BioCryst Pharmaceuticals (BCRX): Update Regarding Peramivir

Cell Therapeutics, Inc.(CTIC): $15MM Loan Financing Agreement

Biotech Stocks Reviews